More articles from Cancer Immunotherapy

You have accessRestricted access
Integration of HSP90 inhibitors in combinational immunotherapy targeting receptor tyrosine kinases (RTKs) in cancer (131.45)
Aparna Rao, Mayumi Kawabe and Walter Storkus

J Immunol 184 (1 Supplement) 131.45; April 1, 2010,
You have accessRestricted access
Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate results in an increase in CD4+ and CD8+ T cells and a decrease in Foxp3+ cells in tongues of mice bearing carcinogen-induced premalignant oral lesions. (131.24)
Anna-Maria Clark and M. Rita Young

J Immunol 184 (1 Supplement) 131.24; April 1, 2010,
You have accessRestricted access
Combination of CTLA-4 blockade with anti-CD40/IL-2 immunotherapy augments the CD8+ T cell response in resting and tumor-bearing mice (131.17)
Gail Sckisel, Ngabo Nzigira, Andrew Hurwitz, Bruce Blazar and William Murphy

J Immunol 184 (1 Supplement) 131.17; April 1, 2010,
You have accessRestricted access
Polyelectrolyte microcapsules: antigen delivery vehicles for potent induction of CTL responses (131.34)
Johan Grooten, Bruno De Geest, Thomas Naessens, Stefaan De Smedt and Stefaan De Koker

J Immunol 184 (1 Supplement) 131.34; April 1, 2010,
You have accessRestricted access
Long-term cytokine therapy with IL-15/IL-15Rα complexes leads to impaired NK cell function (131.11)
Shannon Turley, Mark Rubinstein, Ananda Goldrath and Kutlu Elpek

J Immunol 184 (1 Supplement) 131.11; April 1, 2010,
You have accessRestricted access
Adoptive co-transfer of tumor specific CD4⁺ T cells awakens host protective immunity to MHC-II^- ovarian cancer through CD40-mediated licensing of dendritic cells and CCL5 secretion. (131.14)
Yolanda Nesbeth, Diana Martinez, Seiko Toraya, Uciane Scarlett, Juan Cubillos-Ruiz, Melanie Rutkowski and Jose Conejo-Garcia

J Immunol 184 (1 Supplement) 131.14; April 1, 2010,
You have accessRestricted access
Provision of CD4+ T cell help preferentially enhances anti-tumor immunity of high avidity T cells (131.19)
Ziqiang Zhu, Vinod Singh, Vincenzo Bronte, Lionel Feigenbaum and Arthur Hurwitz

J Immunol 184 (1 Supplement) 131.19; April 1, 2010,
You have accessRestricted access
Antigen nonspecific memory CD8 T cells expand and gain effector function in response to immunotherapy or to viral infection (131.28)
Danice Wilkins, Julia Tietze, Kory Alderson, Jon Weiss, Myriam Bouchlaka, Stephen Priest, Dennis Taub, Robert Wiltrout, Dan Longo, Nicole Baumgarth, Bruce Blazar, Doug Redelman and William Murphy

J Immunol 184 (1 Supplement) 131.28; April 1, 2010,
You have accessRestricted access
Vaccination with tumor cell lysate plus CpG oligodeoxynucleotides elicits tumor-specific T cells with potent antitumor efficacy in adoptive immunotherapy (131.31)
Maki Shindo and Wei Chen

J Immunol 184 (1 Supplement) 131.31; April 1, 2010,
You have accessRestricted access
TNFRSF25 agonists as potent cancer vaccine adjuvants (131.25)
Taylor Schreiber and Eckhard Podack

J Immunol 184 (1 Supplement) 131.25; April 1, 2010,

Main menu

User menu

Search

More articles from Cancer Immunotherapy

Pages

Navigate

For Authors

General Information

Journal Services